Defects in gp91-phox, the large subunit of cytochrome bm (b& give rise to X-linked chronic granulomatous disease (CGD), a rare inherited condition characterized by an extreme susceptibility to bacterial and fungal infection. In the majority of cases, the phagocytes are unable to generate any superoxide owing to complete absence of the flavocytochrome. However, a small minority of these patients do have some phagocytic oxidase activity. We describe here an analysis of the molecular basis of the disease in three such variant patients with lesions in the gene coding for gp91-phox on the X chromosome. Three different genetic lesions were found, resulting in the substitution of tyrosine for cysteine 244, a deletion of one of three lysines 313 through 315, and the deletion of the six C-terminal amino acids, respectively. The functional consequences of these defects on oxi-HRONIC granulomatous disease (CGD) is a rare inherited disorder in which phagocytic cells are unable to generate superoxide, resulting in the defective killing of some ingested microorganisms and an increased predisposition to bacterial and fungal infections.' Superoxide is produced by a membrane-bound NADPH oxidase system that is assembled from both membrane and cytosolic components. The membrane-bound component is flavocytochrome b558 (also b-245)rZ.3 a heterodimer composed of a 22-kD ( a ) subunit, p22-phox, and a heavily glycosylated 76-to 92-kD (p) subunit,4.' gp91-phox. gp91-phox is a member of the flavin nucleotide reductase (FNR) family of reductases, having binding sites for NADPH and flavin adenine dinucleotide (FAD) cofactors.6 The location of the heme is uncertain. The cytosolic factors that are required for the activation of electron transport and translocate to the membrane upon tim mu la ti on^.^ include p47-phox, p67-phox, 1 4 3 and p40-phox. I6 The system also requires a small guanosine triphosphate binding protein, p21'". '7,'8 Genetic lesions in any of the oxidase components (other than p40-phon and p21'" for which lesions have not yet been identified) result in CGD, but defects in the X-linked gene for the p chain of the flavocytochrome are the most prevalent, leading to about two thirds of cases." The classical Xlinked phenotype is characterized by total absence of NADPH oxidase activity and both subunits of the flavocytochrome, which are required for mutual stability." In addition, several cases of a less common form of X-linked CCD, which is referred to as "X-variant" CGD and which differs from the classical phenotype in having reduced rather than absent oxidase activity, have been de~cribed.'"~' We have studied the molecular defect in three unrelated X-variant CGD cases with different levels of residual oxidase activity and variable abundance of the two subunits of the flavocytochrome.
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C MATERIALS AND METHODS
Patients. Patient 1, a male, was born in 1980 to two healthy unrelated parents. At the age of 2.5 years was treated for an abscess in the occiput. He had continuous ear infections between the ages of 5 and 9 years but was otherwise fairly well until the age of 10 years, when he developed an abscess and then a chronic infection dase activity was a reduction to 12%. 3.6%. and 2.1% of the normal levels, respectively. Corresponding levels of gp91-phox were 20%. 8%. and 16% of normal classifving these patients as X91-. Microbicidal assays showed that killing of Staphylococcus aureus was grossly impaired in cells in which there was 12% normal activity. This implies that if gene therapy is to be applied, it must restore oxidase activity to a much higher level than that present in the cells of this patient. The sites of two of the mutations were analyzed on a model of the C-terminal half of the gp9l-phox, based on the crystal structure of the homologous protein ferrodoxin NADP reductase. Possible structural consequences of the mutations were examined. 0 1995 by The American Society of Hematology.
in the right axilla. Over the past 2 years he has spent 6 weeks in the hospital because of severe infections of the skin and scalp. His mother and only sister were identified as carriers, and he has one affected brother who has also had numerous infections, most notably of the nasal sinuses, some of which required hospitalization.
Patient 2 was born in 1982 to healthy unrelated parents. He developed skin abscesses at 3 weeks of age, and subsequently a colitis resembling Crohn's disease. He has had repeated skin abcesses and chronic mouth ulcers, and at the age of 9 years, he developed a liver abcess.
Patient 3 was born in 1976 to healthy unrelated parents. He developed axillary lymphadenitis after a Bacille Calmette-Gukrin (BCG) vaccination and developed an axillary abcess at the age of 3 years, which required surgical drainage. At the age of 4.5 years, he developed a bilateral interstitial pneumonia.
Nitroblue-tetrazolium slide test was performed as described by Borregaard et al.'* Superoxide generation was measured by the superoxide dismutase inhibitable reduction of cytochrome c.~' Neutrophils were purified from peripheral blood taken into 5 IU/ mL heparin by dextran sedimentation, followed by separation on Ficoll-Hypaque (Lymphoprep; Nycomed Pharma AS, Oslo Norway) and hypotonic 1ysk3* Western blotting. Neutrophils were suspended in (6% [wUwt] sucrose; 1.8 mmoVL NaCl; 60 mmoliL KCI; 2.3 mmoliL M g Q ; 6 mmol/L Pipes, pH 7.3) supplemented with 1 p m o K diisopropyl flourophosphate, 1 pmoVL phenylmethylsulphonyl flouride, 1 pmoV L chymostatin, and 1 p m o m leupeptin and were disrupted by sonication on ice for 3 to 5 seconds in a sonicator (MSE Instruments; Sanyo Gallenkamp, Middlesex, UK) at 8 pm amplitude, and centri- fuged at 250g at 4°C for 5 minutes in a microcentrifuge. The resulting postnuclear supernatant (PNS) was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 12.5% gel (30 to 40 pg protein per track). The proteins were then transferred to a reinforced nitrocellulose membrane (0.45 pm, Schleicher & Schuell, Dassel, Germany) using the semidry transfer system (LKB Multiphor; LKB, Uppsala, Sweden) at 00.8 mA/cm' for 120 minutes. The blots were blocked with (5% dried skimmed milk, I % bovine serum albumin, 5% fetal bovine serum, 1 m o m glycine, 0.01% Tween, in TRIS-buffered saline), incubated with monoclonal antibodies (MoAbs) 449 or 48 reacting with p22-phox and gp91-phox, respectively (a gift from A.J. Verhoeven3'), and developed with a horseradish peroxidase-conjugated goat-antimouse IgG (1 :3500; Promega, Madison, WI) by enhanced chemiluminescence detection (ECL; Amersham Ltd, Bucks, UK). The flavocytochrome level in each patient was estimated by densitometry (Enhanced Laser Densitometer; LKBPharmacia, Uppsala, Sweden) of Western blots and developed by ECL. A standard curve was prepared by loading serial dilutions of the normal PNS, where 40 pg of normal PNS corresponded to 100%. Forty micrograms of the patient's PNS was loaded on the gel and compared with the normal standards by densitometry of both subunits bands. Care was taken to ensure that the signal produced by the patients cells fell within a linear region of the standard curve.
Mutation analysis.
The numbering of nucleotides and amino acids used in this paper was according to the system of Orkin."
Total cellular RNA was isolated from Epstein-Barr virus-transformed B-Iymphocytes3'~'' as described by Chomczynski and Sacchi." Avian myeloblastosis virus reverse transcriptase (Promega) was used for the synthesis of the first cDNA strand using l pg total RNA primed with (dT),z~,x or sequence specific primer 0 6 in 20 pL reaction as described by the manufacturer (Promega). The I .7-kb open reading frame of the flavocytochrome b was amplified in three overlapping fragments (1-624, 539-1222, and 1127-1746 bp) using three pairs of synthetic primers with one primer of each pair biotinylated at its 5' end (oligonucleotides pl and p2; p3 and p4; and 05 and 86, Table I ). For each pair of primers, 5 p L of the reverse transcriptase reaction was amplified by polymerase chain reaction (PCR) in a 50 pL reaction (40 cycles of 30 seconds at 93°C I minute at 60°C. 2 minutes at 74OC)."
Solid phase sequencing3' was performed on the biotinylated PCR product adsorbed to streptavidin-coated magnetic beads (Dynal AS, Oslo, Norway). Sequencing was performed as described in the Sequenase manual (US Biochemicals, Cleveland, OH) and the reactions analyzed on standard 6% polyacrylamide denaturing gels. Template for DNA sequencing on the 3' end of the gp91-phox coding sequence of patient 3 was prepared by PCR amplification of genomic DNA, where 2 pg was used to amplify the region from base 1.573 (exon 12) to 1,746 (exon 13), thus amplifying intron 12 in the process using primers @7-/36 (Table I) . The resulting PCR product of = l .2 kb was blunt ended by the addition of S U Klenow fragment to I p g amplified DNA in a reaction containing 1 X PCR buffer and 6 mmol/L deoxynucleotide triphosphates. The reaction was incubated for 20 minutes at room temperature, The tilled DNA was agarose gel purified and precipitated with ethanol. The purified DNA fragment was ligated to Snlu I cut blue-script plasmid (Stratagene, La Jolla, CA) using T4 DNA ligase (NBL, Northumberland, UK). The products of the ligation reaction were used to transform XLI-Blue (Stratagene) competent cells that were plated on ampicillin agar plates. Positive clones were picked by screening plate lifts with radiolabeled DNA probes corresponding to this region. Patient 3 and eight positive clones from each normal control were used for sequencing by US Biochemicals' sequenase method.
RNu.se protecfion experimenfs. Probe constructs used for the RNase protection experiment were made by digesting a cDNA clone (extending from the Psf I site at base number 179 to the Kpn I site at 3,654) in pGEM-4 vector (Promega) with restriction enzymes that cut once in the vector and once in the coding sequence to eliminate unwanted cDNA sequences at the 3' end of the cDNA, thus bringing the SP6 RNA promoter into proximity with different regions of the cDNA, for the synthesis of antisense RNA probes.
ASuc I was prepared by digesting with Suc I, which cuts the cDNA insert of the gp9 1 -phox at base number 1,903. The clone was then recircularized and digested with the Stu 1 restriction enzyme, which cuts at base number 1,523. The other probe, A5.w 361, was made in three steps of digestion and ligation: ( I ) the Pst I-Kpn 1 clone was cut with EcoRI, which cuts once in the polylinker and once in the insert at 1,567 bp. and recircularized: (2) this was then cut with Hindlll (polylinker) and Avu 1 (insert S' end 398 bp) and recircularized; ( 3 ) the product of step 2 was cut with EcoRI and Bsu 361 (insert 3' end 1,049 bp). and recircularized; and (4) finally. the product of step 3 was cut with Ncn I (insert 675 bp). The precise areas covered by the two probes are as follows:
ABsu 361 probe, nucleotides 67.5 through 1,049; ASuc I probe nucleotides 1,523 through 1,903.
Radiolabeled cRNA probes, ASuc I, and ABsn 361 were prepared using 1 pg of the linearized cDNA clone and SP6 RNA Polymerase under conditions recommended by the manufacturer (Promega). Five nanogram!, of each cRNA radiolabeled probe was mixed with 1 5 to 20 pg of total cellular RNA and 20 pg of yeast tRNA and incubated under oil overnight at 42°C. The resulting hybrids were digested with 4.2 p.g/mL RNase A and 200 U/mL RNase TI. The reaction product were separated on a 6% denaturing polyacrylamide gel, dried, and autoradiographed with Hyperfilm MP (Amersham) at -70°C with intensifying screens for up to 1 week.
Iodination reactions were performed as described by Klebanoff and Clark.'" The reaction mixture consisted of 4 mmol/L sodium phosphate buffer pH 7.4; 128 mmol/L NaCI; 12 mmol/L KCI: 10 mmol/L CaClz; 2 mmol/L MgCI,; 80 pmol/L Nal (40 nmol in 0.5 mL reaction; 0.8 pCi of "'1); 2 mmol/L glucose; 3% normal serum; 0.5 mg of Zymosan boiled, washed, and resuspended in phosphatebuffered saline (PBS), and 2.5 X 10' polymorphonuclear leukocytes (PMNs) in a final volume of 0.5 mL. Iodination by resting cells was measured in the absence of zymosan. The reaction mixture was incubated at 37°C for 30 minutes before starting the reaction by the addition of the PMNs. The reaction was terminated after varying times by the addition of 0. I mL of 10 mmol/L sodium thiosulphate and I mL of cold 10% trichloroacetic acid (TCA). The precipitate was pelleted by centrifugation at IS,000g for 5 minutes in a microcentrifuge at 4"C, was washed four times with I .0 mL of 10% TCA, and the radioactivity was counted in a gamma counter (Universal Gamma Counter; LKB). 
RESULTS
All three patients showed weakly staining cells on the nitroblue tetrazolium (NBT) slide test with a mosaic pattern of weak and strong staining of cells from their mother, confirming the X-linked pattern of inheritance. Table 2 Patient 2 had very little oxidase activity (3.6%) and a similarly reduced flavocytochrorne b (8% to 9%). In patient 3, there was a discrepancy between the very low oxidase activity (2.1%) and proportionally greater amounts of flavocytochrome (16% to 24%).
Killing of S aureus by cells from patient 1 was markedly defective and comparable with the levels observed in cells from a patient with classical CCD (Fig 2) despite normal phagocytosis (not shown). Iodination by PMNs in patient 1 was found to be reduced a normal amount of a normal sized transcript in all the pato approximately the same level as superoxide production.
tients (data not shown).
In the patient 5.4 2 0.8 (n = 3 ) nmol of iodine were incorpoThe mutations found in the three patients are shown in rated/107 cellsh, amounting to 1 1 % of the normal levels of Fig 3. In patient I (Fig 3A) , three nucleotides wcre deleted 49.0 2 4.4 (n = 3) nrn0l/l0~h comparable with the 12% of from an AAG trinucleotide repeat in bases 949 through 957 oxidase activity.
in the cDNA resulting in the loss of one of a group of three Northern blot analysis of mRNA showed the presence of lysines at positions 313 through 3 IS. In patient 2 (Fig 3B) .
For personal use only. on April 3, 2017. by guest www.bloodjournal.org From a single base G + A substitution at nucleotide 743 predicts the nonconservative replacement of cysteine 244 by a tyrosine. In patient 3 (Fig 3C) . a tandem duplication of the 31 bases between 1.672 and 1.702 generates a premature stop at codon 565. deleting six amino acids from the C-terminus. The position of the two mutations that lie in the region modeled by Taylor et al" are shown in Fig 4. A and B .
The mutations detected in the PCR-based analysis were confirmed by RNase protection (Fig S) . using whereas a mutation at position 743 in patient 2 generates two fragments of 306 and 68 bases. The ASm I probe consists of the antisense cRNA of the gp91-phox nucleotide sequence 1,523 through 1,903. In patient 3, a cut at position 1,672 generates two fragments of 231 and 149 bases. In all cases, fragments of the size predicted from PCR analysis were detected, except for the 68-bp fragment, which was probably too diffuse to visualize on a 6% gel.
DISCUSSION
The structure of the flavocytochrorne b of the NADPH is of considerable interest. Its function requires access of the substrate, NADPH, from the cytosol, and it must also allow For personal use only. on April 3, 2017. by guest www.bloodjournal.org From for hydrophobic, membrane-spanning helices to permit the translocation of the product, superoxide, to the exterior. From a structural point of view, gp91-phox can be divided roughly into two halves; the N-terminus contains a number of hydrophobic helices,42 whereas the C terminus is much more hydrophilic and contains the FAD and NADPH binding sites.' The functional interaction of the two subunits remains to be established. Both are required for correct processing in the Golgi, targeting to the vacuole, and ~tability.~' Analysis of mutations that produce CGD provides important information as to the structural organization of the flavocytochrome. This has been facilitated by the construction of a model of the C-terminal half of gp91-phox based upon the crystal structure of ferrodoxin NADP reductase. Most of the mutations result in complete instability and loss of both subunits. Occasional mutations have been described in which there is high level of expression of the proteins with total loss of function. A mutation (Asp,, + Gly) in gp91-phox in the region of a helix predicted to overly the nucleotide binding groove is characterized by failure of the translocation of the cytosolic phox proteins,44 giving credence to the theory that these proteins might activate electron transport by attaching to and moving this helix aside, thereby providing NADPH access to the FAD moiety.42 A mutation in the Proline-rich segment of the C-terminus of p22-phox (Prolsh + Gln) leads to CGD," this mutation prevents the binding of the p47-phox protein SH3 domain in ~i t r o .~~.~~ Mutations resulting in variant CGD with a partial loss of oxidase activity are of interest because they either result from structural disorganization leading to incomplete loss of protein, to partial functional disorganization, or to a mixture of the two. The model of the C-terminal hydrophilic half of gp91-phox provides a template upon which to start examining the impact of some of these mutations upon structure and function. To date, the precise molecular defect has been identified in seven patients with variant CCD4* of which five involved amino acid substitutions in gp91-phox (at amino acid positions 56, 156, 244, 309, and 389).4K.49 The substitution at position 56 located in the N-terminus resulted in a 75% to 80% loss of oxidase activity, and a loss of 40% of the flavocytochrome. The remaining four resulted in a greater loss (70% to 90%) of the flavocytochrome and a concomitant (80% to 97%) diminution of NADPH oxidase a~tivity.~' These mutations appear to have their effect through destabilization of the proteins rather than altering the electron transport. Other variant patients have been described in which the function of the molecule is disturbed to a much greater extent than the stability. For example, deletion of amino acids 488 through 497'" resulted in a normal level of the cytochrome, but only 6% of oxidase activity. In all three of our patients there was a loss of most of the flavocytochrome proteins. In addition, in patient 3, and probably also in 1, there is a disproportionate loss of oxidase activity suggesting an additional functional impairment of the residual protein.
Although patient I had 12% of normal oxidase activity, this was not associated with a much less severe clinical presentation, and both he and his affected brother were repeatedly hospitalized with frequent and severe infections. In contrast, the patient described by Schapiro et also had only 6% oxidase activity, but did not present until the age of 69 years. The basis of the increased susceptibility to infection in our patient was confirmed as being caused by an inability of his neutrophils to kill S aureus, which was comparable with the levels of killing observed in classical X-CGD. This is important because it indicates that if the gene therapy approach to treatment is to be effective, it must result in the reconstitution of oxidase activity well above the 10% observed in this patient. The results in this patient also indicate that iodination levels in neutrophils are limited by the levels of substrate.
As referred to above, substitution of a cysteine 244 in patient 2 has been described previously. Unlike the substitution seen here, where the cysteine is replaced by a tyrosine, in the previously reported case, a G + C transversion results in the replacement of cysteine 244 by serine." Although both cases showed similar, low levels of PMA-stimulated superoxide production at about 3% of normal, they appear to have different amounts of proteins with about 8% in our patient as compared with 39% in the Cys + Ser mutation." Alternatively, because the cytochrome was estimated by Western blotting in our study and spectroscopically in the other, this difference could be methodologic. If indeed the Cys + Tyr is more disruptive than the Cys + Ser, it could be as a result of the large tyrosine aromatic side chain, which is likely to cause greater disruption of the surrounding amino acids than the smaller aliphatic side chain of serine.
In patient 3, the cDNA analysis indicated the presence of a duplication of 3 1 bases (1,672 through 1,7021, in the coding sequence of exon 13, which encodes the C-terminal region of the protein. Although this patient has a sizeable quantity of flavocytochrome (16% to 24% of normal), the activity of the molecule seems more severely affected with superoxide production at only 2.1 % of normal. The structural model of Taylor et ai4* may provide an explanation for this discordance. It was suggested from the model that the last amino acid (570) that is deleted from patient 3 is one of two amino acids critical to the binding of FAD. The juxtaposition of the C-terminus and the FAD and NADPH cofactors is shown in Fig 4A. Therefore, a probable consequence of the deletion in patient 3 could be to increase the K,, for one or both cofactors. Alternatively, the loss of the last six amino acids could serve to prohibit conformational changes in gp91-phox that are necessary for the activation of electron transport.
